Prospective study of the feasibility of point-of-care testing strategy for carbapenem-resistant organism detection

BACKGROUND/AIMS:  In an investigator-initiated, prospective study, we evaluated the feasibility of a five-gene sequence point-of-care (POC) testing strategy (Xpert CARBA-R Assay, Cepheid Inc., Sunnyvale, CA, USA), compared to reference laboratory PCR (48 – 72 hours turnaround time, two gene sequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Pannala, Rahul, Baldwin, Bruce, Aluru, Vijay, Grys, Thomas E., Holmes, Jordan, Miller, Laurence J., Harrison, M. Edwyn, Nguyen, Cuong C., Tenover, Fred C., Persing, David, Faigel, Douglas O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766332/
https://www.ncbi.nlm.nih.gov/pubmed/29340299
http://dx.doi.org/10.1055/s-0043-122141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766332/
https://www.ncbi.nlm.nih.gov/pubmed/29340299
http://dx.doi.org/10.1055/s-0043-122141

Ejemplares similares